Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Thyrocare Technologies Limited

Thyrocare provides laboratory testing services, including health screening and diagnostic tests.

Metric
Company Name	Thyrocare Technologies Limited
Symbol	THYROCARE
MSH ID	COM:THYROCARE
Market	STOCKS
Sector	Healthcare
Industry	Medical - Diagnostics & Research
Country	IN
Stage
Employee Count	1.65K
Website	thyrocare.com
LinkedIn
Founders

Metric
Market Cap	404.42M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	67.52M
Revenue (LTM)
Revenue (NTM)
Gross Profit	29.55M
EBITDA	16.23M
Operating Income	10.68M
Net Income	8.35M
EPS	0.16
Diluted EPS	0.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.71
Operating Profit Margin	0.17
EBITDA Margin	0.24
Net Profit Margin	0.13
Return on Equity	0.17
Return on Assets	0.12
Return on Capital Employed	0.19

COM:THYROCARE

Thyrocare

Last Close

956.15

25/11 09:40

Market Cap

34.26B

Beta: -

Volume Today

116.34K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	50.17
P/B Ratio	6.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.07
EV Multiple	30.54

Metric
Days Sales Outstanding	36.95
Days Payables Outstanding	39.56
Days Inventory Outstanding	84.06
Operating Cycle	111.81
Cash Conversion Cycle	40.85
Asset Turnover	0.92

Metric
Operating Cash Flow	19.41M
Free Cash Flow	12.14M
Cash Flow to Debt	2.92
Operating Cash Flow/Sales	0.16
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	4.71M
Accounts Receivable	3.87M
Inventory	5.61M
Goodwill	12.28M
Debt to Capitalization	0.05
Debt to Assets	0.08
Current Ratio	3.05
Quick Ratio	2.55

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue
SG&A to Revenue